SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 13.65 |
| Enterprise Value ($M) | 18.04 |
| Book Value ($M) | -18.82 |
| Book Value / Share | -1.75 |
| Price / Book | -0.73 |
| NCAV ($M) | -19.18 |
| NCAV / Share | -1.78 |
| Price / NCAV | -0.71 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.55 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.20 |
| Current Ratio | 0.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.11 |
| Assets | 4.46 |
| Liabilities | 23.28 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 20,032 | 37,431 | 53.52 | |
| 25,478 | 76,208 | 33.43 | |
| 275,480 | 641,279 | 42.96 | |
| 27,484 | 76,095 | 36.12 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NLSP – NLS Pharmaceutics AG | NRBO – NeuroBo Pharmaceuticals, Inc. |
| NRSN – NeuroSense Therapeutics Ltd. | NVCT – Nuvectis Pharma, Inc. |
| OCEA – Ocean Biomedical, Inc. |
Financial data and stock pages provided by
Fintel.io